Medical Science Liaison Research
|Roles, Resourcing and Management of Medical Science Liaisons |
As the medical science liaison (MSL) function continues to gain importance in building and strengthening KOL relationships, medical affairs leaders are continually re-assessing their MSL management practices to be successful in the competitive environment... (ID PSM-234) |
Companies Profiled: Abbott Labs, Jazz Pharmaceuticals, Kadmon Pharmaceuticals, Covidien, more ...
Price: $5675.00 Free Excerpt Available
|Investigator Initiated Trials Management |
As pharmaceutical and medical device companies improve their investigator-initiated trial (IIT) programs, it is critical to properly vet each proposal and approve the ones that demonstrate scientific merit and align with corporate objectives... (ID POP-282) |
Companies Profiled: Abbvie, Allergan, Alnylam Pharmaceuticals, Bayer, more ...
Price: $5500.00 Free Excerpt Available
|Medical Affairs Strategies to Deliver Value to Payer Groups |
In recent times, pharmaceutical companies have turned to their Medical Affairs function to establish meaningful relationships with payer groups, including Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs), owing to their rising influence on market access... (ID POP-284) |
Companies Profiled: Abbott, Abbvie, Actelion, Astellas, more ...
Price: $5000.00 Free Excerpt Available
|The iPad: How MSLs Use It to Deliver Science and Data to HCPs |
As pharma companies find it more difficult to connect with physicians and KOLs, advances and access to technology have opened doors for bio-pharmaceutical companies to adapt and enhance new processes and tools for superior performance and gain competitive edge in the market... (ID POP-252) |
Companies Profiled: Abbott Animal Health, Abbvie, Acorda Therapeutics, Amgen, more ...
Price: $2500.00 Free Excerpt Available